Explosive Growth in Generative AI in Pharmaceuticals: Market Set to Reach $9.36 Billion by 2030 at 30.9% CAGR - GlobeNewswire

Pharmaceutical companies are heavily investing in AI to discover drugs faster and more efficiently. This could accelerate development of treatments for diseases and lower drug development costs.